EFG
LLY icon

Elevated Financial Group’s Eli Lilly LLY Stock Holding History

Elevated Financial Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Sell
986
-2,516
-72% -$2.57M 0.32% 42
2026
Q1 		$3.22M Buy
3,502
+2,322
+197% +$2.35M 1.05% 21
2025
Q4 		$1.27M Buy
+1,180
New +$1.13M 0.44% 35

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Elevated Financial Group's LLY Position: Q2 2026 in Review

Elevated Financial Group reduced its Eli Lilly (LLY) stake by 72% in Q2 2026, selling an estimated $2.57M and leaving 986 shares worth $1.18M. The position accounts for 0.32% of the portfolio, ranked #42.

Elevated Financial Group first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.22M in Q1 2026. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Elevated Financial Group held 986 shares of Eli Lilly worth $1.18M as of Q2 2026.
  • Elevated Financial Group sold 2,516 Eli Lilly shares in Q2 2026, an estimated $2.57M.
  • Eli Lilly made up 0.32% of Elevated Financial Group's portfolio in Q2 2026, its #42 holding.
  • Elevated Financial Group first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Elevated Financial Group's Eli Lilly position peaked at $3.22M in Q1 2026.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Elevated Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.